The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study

被引：0
|
作者：
Arwa Younis
Dana Eskenazi
Ronen Goldkorn
Jonathan Leor
Nili Naftali-Shani
Enrique Z. Fisman
Alexander Tenenbaum
Ilan Goldenberg
Robert Klempfner
机构：
[1] Sheba Medical Center,The Leviev Heart Center
[2] Tel Aviv University,Sackler School of Medicine
[3] Cardiovascular Diabetology Research Foundation,Heart Research Follow
[4] University of Rochester,up Program
来源：
Cardiovascular Diabetology | / 16卷
关键词：
Interleukin 1 beta; Vildagliptin; Dipeptidyl peptidase-4 inhibitors; Gliptins; Metformin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The addition of vildagliptin to metformin prevents the elevation of interleukin 1β in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study
    Younis, Arwa
    Eskenazi, Dana
    Goldkorn, Ronen
    Leor, Jonathan
    Naftali-Shani, Nili
    Fisman, Enrique Z.
    Tenenbaum, Alexander
    Goldenberg, Ilan
    Klempfner, Robert
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [2] Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION)
    Ji, L-N
    Pan, C-Y
    Lu, J-M
    Li, H.
    Zhu, D-L
    Li, Q.
    Li, Q-F
    Peng, Y-D
    Tian, H-M
    Yao, C.
    Zhao, Z-G
    Wang, L.
    Wang, B-H
    DIABETES OBESITY & METABOLISM, 2016, 18 (08) : 775 - 782
  • [3] Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study
    Sun, Rui
    Yuan, Lu
    Shen, Yun
    Shen, Ziyang
    Ding, Bo
    Ma, Jianhua
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2911 - 2919
  • [4] A comparison of the effects of liraglutide, metformin, and gliclazide in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease: a prospective, randomized, open-label trial
    Feng, Wenhuan
    Gao, Caixia
    Bi, Yan
    Wu, Min
    Li, Pi
    Shen, Shanmei
    Hu, Yun
    Chen, Wei
    Liu, Yiqiao
    Zhu, Dalong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (SUPP 2) : 7 - 8
  • [5] Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial
    Zhang, Xiuzhen
    Xu, Dan
    Xu, Ping
    Yang, Shufen
    Zhang, Qingmei
    Wu, Yan
    Yuan, Fengyi
    ENDOCRINE CONNECTIONS, 2021, 10 (09) : 1045 - 1054
  • [6] The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study
    Moon, Jun Sung
    Ha, Kyoung Soo
    Yoon, Ji Sung
    Lee, Hyoung Woo
    Lee, Hyun Chul
    Won, Kyu Chang
    ACTA DIABETOLOGICA, 2014, 51 (02) : 277 - 285
  • [7] The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study
    Jun Sung Moon
    Kyoung Soo Ha
    Ji Sung Yoon
    Hyoung Woo Lee
    Hyun Chul Lee
    Kyu Chang Won
    Acta Diabetologica, 2014, 51 : 277 - 285
  • [8] Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study
    Erande, Suhas
    Mukhopadhyay, Jotideb
    Dange, Amol
    Deogaonkar, Anushka
    Birla, Ashish
    Doshi, Chetan
    Revankar, Santosh
    Sridhar, S. B.
    Kumar, Neeraj
    V. Kadam, Pramod
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [9] Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study
    Otowa-Suematsu, Natsu
    Sakaguchi, Kazuhiko
    Nakamura, Tomoaki
    Hara, Kenta
    Kishi, Minoru
    Hashimoto, Naoko
    Yokota, Kazuki
    Yoshino, Hiroshi
    Kuroki, Yasuo
    Nishiumi, Tomoko
    Sou, Anna
    Komada, Hisako
    Okada, Yuko
    Hirota, Yushi
    Tamori, Yoshikazu
    Ogawa, Wataru
    DIABETES THERAPY, 2018, 9 (05) : 2067 - 2079
  • [10] Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study
    Bayrasheva, Valentina K.
    Pchelin, Ivan Y.
    Dobronravov, Vladimir A.
    Babenko, Alina Yu
    Chefu, Svetlana G.
    Shatalov, Ivan S.
    Vasilkova, Volha N.
    Hudiakova, Natalia, V
    Ivanova, Alexandra N.
    Andoskin, Pavel A.
    Grineva, Elena N.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2020, 64 (04): : 418 - 426
12345